TY - JOUR
T1 - Evidence for involvement of mast cell degranulation and subsequent stimulation of histamine H1 and H2 receptors in radiographic contrast media-increased vascular permeability in rats
AU - Goromaru, Takeshi
AU - Sendo, Toshiaki
AU - Itoh, Yoshinori
AU - Sakai, Naoko
AU - Teshima, Daisuke
AU - Oishi, Ryozo
N1 - Funding Information:
Acknowledgements This research was supported in part by Grant-in-Aid for Scientific Research (C:13672390) from the Ministry of Education, Science, Sports and Culture, Japan.
PY - 2002
Y1 - 2002
N2 - In the present study, the effects of systemic injection of radiographic contrast media (RCM) on vascular permeability was examined in various tissues of rats and the involvement of mast cell histamine in the RCM-induced vascular hyperpermeability subsequently determined. Both ionic (amidotrizoate) and non-ionic RCM (iohexol) enhanced vascular permeability specifically in lungs, as assessed by the extravasation of Evans blue (EB) dye. Another ionic RCM, ioxaglate, also markedly increased pulmonary vascular permeability and decreased pulmonary histamine content, whereby the extent of the reduction correlated well with the vascular hyperpermeability. Depletion of mast cells by prior treatment with compound 48/80 markedly attenuated the ioxaglate-induced enhancement of EB extravasation. The ioxaglate-increased extravasation was also inhibited by the mast cell stabilizer sodium cromoglicate and histamine H1 and H2 receptor antagonists. In isolated rat pulmonary mast cells, ioxaglate induced the concentration-dependent release of β-hexosaminidase, an index of mast cell degranulation. The present findings thus show clearly that RCM causes the degradation of pulmonary mast cells and the resultant release of histamine that in turn increases vascular permeability by stimulating histamine H1 and H2 receptors.
AB - In the present study, the effects of systemic injection of radiographic contrast media (RCM) on vascular permeability was examined in various tissues of rats and the involvement of mast cell histamine in the RCM-induced vascular hyperpermeability subsequently determined. Both ionic (amidotrizoate) and non-ionic RCM (iohexol) enhanced vascular permeability specifically in lungs, as assessed by the extravasation of Evans blue (EB) dye. Another ionic RCM, ioxaglate, also markedly increased pulmonary vascular permeability and decreased pulmonary histamine content, whereby the extent of the reduction correlated well with the vascular hyperpermeability. Depletion of mast cells by prior treatment with compound 48/80 markedly attenuated the ioxaglate-induced enhancement of EB extravasation. The ioxaglate-increased extravasation was also inhibited by the mast cell stabilizer sodium cromoglicate and histamine H1 and H2 receptor antagonists. In isolated rat pulmonary mast cells, ioxaglate induced the concentration-dependent release of β-hexosaminidase, an index of mast cell degranulation. The present findings thus show clearly that RCM causes the degradation of pulmonary mast cells and the resultant release of histamine that in turn increases vascular permeability by stimulating histamine H1 and H2 receptors.
KW - Compound 48/80
KW - H receptor antagonist
KW - H receptor antagonist
KW - Lung
KW - Mast cell histamine
KW - Radiographic contrast media
KW - Vascular permeability
UR - http://www.scopus.com/inward/record.url?scp=0036445840&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0036445840&partnerID=8YFLogxK
U2 - 10.1007/s00210-002-0618-y
DO - 10.1007/s00210-002-0618-y
M3 - Article
C2 - 12444503
AN - SCOPUS:0036445840
SN - 0028-1298
VL - 366
SP - 605
EP - 612
JO - Naunyn-Schmiedeberg's Archives of Pharmacology
JF - Naunyn-Schmiedeberg's Archives of Pharmacology
IS - 6
ER -